Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to $0.77.

  • Lemaitre Vascular's EPS (Basic) rose 5400.0% to $0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.37, marking a year-over-year increase of 2810.81%. This contributed to the annual value of $1.94 for FY2024, which is 4274.57% up from last year.
  • As of Q3 2025, Lemaitre Vascular's EPS (Basic) stood at $0.77, which was up 5400.0% from $0.61 recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's EPS (Basic) ranged from a high of $0.77 in Q3 2025 and a low of $0.16 during Q2 2022
  • Moreover, its 5-year median value for EPS (Basic) was $0.36 (2023), whereas its average is $0.39.
  • As far as peak fluctuations go, Lemaitre Vascular's EPS (Basic) surged by 13529.41% in 2021, and later plummeted by 6000.0% in 2022.
  • Over the past 5 years, Lemaitre Vascular's EPS (Basic) (Quarter) stood at $0.29 in 2021, then decreased by 15.1% to $0.25 in 2022, then skyrocketed by 53.77% to $0.38 in 2023, then rose by 25.47% to $0.48 in 2024, then skyrocketed by 61.07% to $0.77 in 2025.
  • Its EPS (Basic) stands at $0.77 for Q3 2025, versus $0.61 for Q2 2025 and $0.49 for Q1 2025.